NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

10590	Companies
224541	Keywords
153294	Articles
118776	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 05/22/2026 at 22:15, 25 days 22 hours ago

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
Nanobiotix fully exercises underwriters' over-allotment option, raising gross proceeds of approximately $100 million from global offering. Proceeds allocated for development and general corporate purposes

Development Underwriters Proceeds Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 15:35, 27 days 4 hours ago

Nanobiotix Resumes Trading of Ordinary Shares on Euronext Paris

Euronext Paris Biotechnology Trading Resumption Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 15:35, 27 days 4 hours ago

Nanobiotix resumes its negotiations on Euronext Paris

Euronext Paris Biotechnology Qualified Investors NANOBIOTIX ADS Offer
PRESS RELEASE

published on 05/21/2026 at 15:30, 27 days 4 hours ago

Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
Nanobiotix announces trading resumption of its ordinary shares on Euronext Paris following Global Offering. Company pioneers physics-based approaches to expand cancer treatment possibilities

Euronext Paris Cancer Treatment Trading Resumption Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 08:35, 27 days 11 hours ago

Temporary suspension of Nanobiotix shares on Euronext Paris

Euronext Paris Actions Suspension NANOBIOTIX Global Offer
PRESS RELEASE

published on 05/21/2026 at 08:30, 27 days 11 hours ago

Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
Nanobiotix announces temporary trading halt of its ordinary shares on Euronext Paris for Global Offering pricing and allocation confirmation

Euronext Paris Trading Halt Pricing Global Offering NANOBIOTIX
BRIEF

published on 05/21/2026 at 00:24, 27 days 20 hours ago

Nanobiotix Launches Global Follow-On Offering

Biotechnology ADSs Global Offering NANOBIOTIX Biopharmaceutical Investment
PRESS RELEASE

published on 05/21/2026 at 00:19, 27 days 20 hours ago

Nanobiotix Announces Launch of Global Follow-On Offering
Nanobiotix announces launch of global follow-on offering of approximately €75 million ($87 million) for expansion of treatment possibilities. Underwriting by Jefferies, TD Cowen, Stifel

Expansion Treatment Underwriting Global Offering NANOBIOTIX
BRIEF

published on 05/17/2026 at 16:20, 1 month ago

Nanobiotix Presents Promising Early Phase 2 Trial Data for JNJ-1900 in Lung Cancer

Clinical Data Phase 2 Trial NBTXR3 Lung Cancer JNJ-1900
PRESS RELEASE

published on 05/17/2026 at 16:15, 1 month ago

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Nanobiotix presents part 1 data from JNJ-1900 (NBTXR3) in lung cancer at ESTRO 2026, showing promising responses. JNJ-1900 is a novel oncology product activated by radiotherapy

NANOBIOTIX Lung Cancer JNJ-1900 Radioenhancer ESTRO 2026

Accesswire

Published on 06/17/2026 at 16:55, 3 hours 30 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 3 hours 40 minutes ago

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 5 hours 55 minutes ago

Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 6 hours 25 minutes ago

CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 14:00, 6 hours 25 minutes ago

Trifecta Gold Increases Private Placement

View all ACCESSWIRE

EQS Group

Published on 06/17/2026 at 19:10, 1 hour 15 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 1 hour 45 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 1 hour 49 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 2 hours 2 minutes ago

EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG
Published on 06/17/2026 at 18:05, 2 hours 20 minutes ago

WACACO LAUNCHES PRESTINA, A PATENTED MANUAL COFFEE BREWER THAT TURNS THE CUP INTO THE PRESS

Les Echos

Published on 06/17/2026 at 17:40, 2 hours 45 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 11 hours 40 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 8 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 21 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 1 hour ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE